Shopping Cart 0
Cart Subtotal
USD 0

Sage Therapeutics Inc (SAGE) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375

Details

Sage Therapeutics Inc (SAGE)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sage Therapeutics Inc (Sage) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics and medicines for central nervous system (CNS) disorders. It develops drugs based on selective allosteric modulation of CNS synaptic and extrasynaptic receptors of NMDA and GABA. Its flagship product Zulresso (brexanolone) is approved by the US-FDA for the treatment of postpartum depression (PPD). The company's also has various pipeline products for the treatment of indications such as postpartum depression, major depressive disorders, bipolar depression, Parkinson's disease, insomnia, epileptiform disorders and NMDA hypofunction. Sage is headquartered in Cambridge, Massachusetts, the US.

Sage Therapeutics Inc Key Recent Developments

May 02,2019: Sage Therapeutics announces first quarter 2019 financial results and highlights pipeline and business progress

Feb 19,2019: Sage Therapeutics announces fourth quarter and full year 2018 financial results and highlights pipeline and business progress

Jan 23,2019: Sage Therapeutics Appoints Elizabeth Barrett and George Golumbeski to Board of Directors

Nov 06,2018: Sage Therapeutics announces third quarter 2018 financial results and highlights pipeline and business progress

Aug 07,2018: Sage therapeutics announces second quarter 2018 financial results and highlights pipeline and business progress

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Sage Therapeutics Inc-Key Facts

Sage Therapeutics Inc-Key Employees

Sage Therapeutics Inc-Key Employee Biographies

Sage Therapeutics Inc-Major Products and Services

Sage Therapeutics Inc-History

Sage Therapeutics Inc-Company Statement

Sage Therapeutics Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Sage Therapeutics Inc-Business Description

R&D Overview

Sage Therapeutics Inc-Corporate Strategy

Sage Therapeutics Inc-SWOT Analysis

SWOT Analysis-Overview

Sage Therapeutics Inc-Strengths

Sage Therapeutics Inc-Weaknesses

Sage Therapeutics Inc-Opportunities

Sage Therapeutics Inc-Threats

Sage Therapeutics Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Sage Therapeutics Inc, Recent Deals Summary

Section 5-Company's Recent Developments

May 02, 2019: Sage Therapeutics announces first quarter 2019 financial results and highlights pipeline and business progress

Feb 19, 2019: Sage Therapeutics announces fourth quarter and full year 2018 financial results and highlights pipeline and business progress

Jan 23, 2019: Sage Therapeutics Appoints Elizabeth Barrett and George Golumbeski to Board of Directors

Nov 06, 2018: Sage Therapeutics announces third quarter 2018 financial results and highlights pipeline and business progress

Aug 07, 2018: Sage therapeutics announces second quarter 2018 financial results and highlights pipeline and business progress

May 03, 2018: Sage Therapeutics Announces First Quarter 2018 Financial Results and Provides Update on Pipeline and Progress toward Launch Readiness

Feb 22, 2018: Sage Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

Jan 08, 2018: Sage Therapeutics to Provide Pipeline Update at J.P. Morgan Healthcare Conference and Outline Key 2018 Initiatives to Support Planned Evolution to a Fully-Integrated Commercial Biopharmaceutical Company

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Sage Therapeutics Inc, Performance Chart (2014-2018)

Sage Therapeutics Inc, Ratio Charts

Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Sage Therapeutics Inc, Key Facts

Sage Therapeutics Inc, Key Employees

Sage Therapeutics Inc, Key Employee Biographies

Sage Therapeutics Inc, Major Products and Services

Sage Therapeutics Inc, History

Sage Therapeutics Inc, Subsidiaries

Sage Therapeutics Inc, Key Competitors

Sage Therapeutics Inc, Ratios based on current share price

Sage Therapeutics Inc, Annual Ratios

Sage Therapeutics Inc, Annual Ratios (Cont...1)

Sage Therapeutics Inc, Interim Ratios

Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Sage Therapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Sage Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Supernus Pharmaceuticals Inc

Sunovion Pharmaceuticals Inc

Otsuka America Pharmaceutical Inc

Marinus Pharmaceuticals Inc

Edge Therapeutics Inc

Accord Healthcare Pty Ltd

Company Profile

Company Profile Title

Sage Therapeutics Inc (SAGE)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sage Therapeutics Inc (Sage) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics and medicines for central nervous system (CNS) disorders. It develops drugs based on selective allosteric modulation of CNS synaptic and extrasynaptic receptors of NMDA and GABA. Its flagship product Zulresso (brexanolone) is approved by the US-FDA for the treatment of postpartum depression (PPD). The company's also has various pipeline products for the treatment of indications such as postpartum depression, major depressive disorders, bipolar depression, Parkinson's disease, insomnia, epileptiform disorders and NMDA hypofunction. Sage is headquartered in Cambridge, Massachusetts, the US.

Sage Therapeutics Inc Key Recent Developments

May 02,2019: Sage Therapeutics announces first quarter 2019 financial results and highlights pipeline and business progress

Feb 19,2019: Sage Therapeutics announces fourth quarter and full year 2018 financial results and highlights pipeline and business progress

Jan 23,2019: Sage Therapeutics Appoints Elizabeth Barrett and George Golumbeski to Board of Directors

Nov 06,2018: Sage Therapeutics announces third quarter 2018 financial results and highlights pipeline and business progress

Aug 07,2018: Sage therapeutics announces second quarter 2018 financial results and highlights pipeline and business progress

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Sage Therapeutics Inc-Key Facts

Sage Therapeutics Inc-Key Employees

Sage Therapeutics Inc-Key Employee Biographies

Sage Therapeutics Inc-Major Products and Services

Sage Therapeutics Inc-History

Sage Therapeutics Inc-Company Statement

Sage Therapeutics Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Sage Therapeutics Inc-Business Description

R&D Overview

Sage Therapeutics Inc-Corporate Strategy

Sage Therapeutics Inc-SWOT Analysis

SWOT Analysis-Overview

Sage Therapeutics Inc-Strengths

Sage Therapeutics Inc-Weaknesses

Sage Therapeutics Inc-Opportunities

Sage Therapeutics Inc-Threats

Sage Therapeutics Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Sage Therapeutics Inc, Recent Deals Summary

Section 5-Company's Recent Developments

May 02, 2019: Sage Therapeutics announces first quarter 2019 financial results and highlights pipeline and business progress

Feb 19, 2019: Sage Therapeutics announces fourth quarter and full year 2018 financial results and highlights pipeline and business progress

Jan 23, 2019: Sage Therapeutics Appoints Elizabeth Barrett and George Golumbeski to Board of Directors

Nov 06, 2018: Sage Therapeutics announces third quarter 2018 financial results and highlights pipeline and business progress

Aug 07, 2018: Sage therapeutics announces second quarter 2018 financial results and highlights pipeline and business progress

May 03, 2018: Sage Therapeutics Announces First Quarter 2018 Financial Results and Provides Update on Pipeline and Progress toward Launch Readiness

Feb 22, 2018: Sage Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

Jan 08, 2018: Sage Therapeutics to Provide Pipeline Update at J.P. Morgan Healthcare Conference and Outline Key 2018 Initiatives to Support Planned Evolution to a Fully-Integrated Commercial Biopharmaceutical Company

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Sage Therapeutics Inc, Performance Chart (2014-2018)

Sage Therapeutics Inc, Ratio Charts

Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Sage Therapeutics Inc, Key Facts

Sage Therapeutics Inc, Key Employees

Sage Therapeutics Inc, Key Employee Biographies

Sage Therapeutics Inc, Major Products and Services

Sage Therapeutics Inc, History

Sage Therapeutics Inc, Subsidiaries

Sage Therapeutics Inc, Key Competitors

Sage Therapeutics Inc, Ratios based on current share price

Sage Therapeutics Inc, Annual Ratios

Sage Therapeutics Inc, Annual Ratios (Cont...1)

Sage Therapeutics Inc, Interim Ratios

Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Sage Therapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Sage Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Supernus Pharmaceuticals Inc

Sunovion Pharmaceuticals Inc

Otsuka America Pharmaceutical Inc

Marinus Pharmaceuticals Inc

Edge Therapeutics Inc

Accord Healthcare Pty Ltd